KLRS

Kalaris Therapeutics, Inc. Common Stock

71 hedge funds and large institutions have $33.9M invested in Kalaris Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 25 reducing their positions, and 19 closing their positions.

Holders
71
Holders Change
-5
Holders Change %
-6.58%
% of All Funds
1.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
16
Reduced
25
Closed
19
Calls
$202K
Puts
$2K
Net Calls
+$200K
Net Calls Change
-$199K
Name Holding Trade Value Shares
Change
Shares
Change %
Verition Fund Management
76
Verition Fund Management
Connecticut
-$48.2K -2,775 Closed
Amundi
77
Amundi
France
-$33.7K -1,976 Closed
Barclays
78
Barclays
United Kingdom
-$27K -1,532 Closed
Capstone Investment Advisors
79
Capstone Investment Advisors
New York
-$20.6K -1,185 Closed
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$16.1K -928 Closed
Principal Financial Group
81
Principal Financial Group
Iowa
-$15.7K -901 Closed
Wells Fargo
82
Wells Fargo
California
-$13.8K -794 Closed
SG Americas Securities
83
SG Americas Securities
New York
-$13K -765 Closed
Mirae Asset Global Investments
84
Mirae Asset Global Investments
South Korea
-$48.6K -527 Closed
Invesco
85
Invesco
Georgia
-$8.99K -518 Closed
Legal & General Group
86
Legal & General Group
United Kingdom
-$3.04K -175 Closed
QT
87
Quantbot Technologies
New York
-$2.46K -142 Closed
AIP
88
Ameritas Investment Partners
Nebraska
-$1.82K -105 Closed
AB
89
Amalgamated Bank
New York
-$1K -45 Closed
AWM
90
Avior Wealth Management
Nebraska
-$6